Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization

Brain Research

Volumn 804, Issue 2, 1998, Pages 169-176

  Yang, Yi ^a   Shuaib, Ashfaq ^a   Li, Qiu ^a   Siddiqui, Muzaffar M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antiepileptic agent; Focal cerebral ischemia; Infarct volume; Neuroprotection; Rat; Topiramate

Indexed keywords

TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; EMBOLISM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM;

ANIMALS; ANTICONVULSANTS; BRAIN ISCHEMIA; CEREBRAL ARTERIES; FRUCTOSE; HEMORRHAGE; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; RATS; RATS, WISTAR;

EID: 0032494239     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00410-7     Document Type: Article

References (48)

1. H.S. Bechelard, Biochemistry of centrally-active amino acids, in: F.V. DeFeudis, P. Mandel (Eds.), Advances in Biochemical Psychopharmacology, Raven Press, New York, 1981, pp. 475-498.
2. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowaski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476.
3. E. Ben-Menachem, Potential antiepileptic drugs, in: R.H. Levy, R.H. Mattson, B.S. Meldrum (Eds.), Topiramate, Antiepileptic Drugs, 4th edn., Raven Press, New York, 1995, pp. 1063-1070.
4. Bourgeois B.F.D. New antiepileptic drugs. Curr. Opin. Pediatr. 8:1996;543-548.
5. Brown S.D., Wolf H.H., Swinyard E.A., Twyman R.E., White H.S. The novel anticonvulsant topiramate enhances GABA-mediated chloride flux. Epilepsia. 34:1993;122-123. Suppl. 2.
6. Butcher S.P., Sanberg M., Hagberg H., Hamberger A. Cellular origins of endogenous amino acids released into the extracellular fluid of the rat striatum during severe insulin-induced hypoglycemia. J. Neurochem. 48:1987;722-728.
7. Caplan L.R. Intracerebral haemorrhage. Lancet. 339:1992;656-658.
8. Casto L., Caverni L., Camerlingo M., Censori B., Moschini L., Servalli M.C., Partziguian T., Belloni G., Mamoli A. Intra-arterial thrombolysis in acute ischaemic stroke: experience with a superselective catheter embedded in the clot. J. Neurol. Neurosurg. Psychiatry. 60:1996;667-670.
9. Chen J., Graham S.H., Simon R.P. A comparison of the effects of a sodium channel blocker and an NMDA antagonist upon extracellular glutamate in rat focal cerebral ischemia. Brain Res. 699:1995;121-124.
10. Chen S.T., Hsu C.Y., Hogan E.L., Banik N.L., Huan H.Y., Balentine J.D. Brain calcium content in ischemic infarction. Neurology. 37:1987;1227-1229.
11. Coulter D.A., Sombati S., DeLorenzo R.J. Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons. Epilepsia. 34:1993;123. S2.
12. DeGraba T.J., Ostrow P., Hanson S., Frotta J.C. Motor performance, histologic damage and calcium influx in rats treated with NBQX after focal ischaemia. J. Cereb. Blood Flow Metab. 14:1994;262-268.
13. Drejer J., Benveniste H., Diemer N.H., Schousboe A. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and vitro. J. Neurochem. 45:1985;145-151.
14. Edmonds H.L. Jr., Jiang Y.D., Zhang R.Y., Shank R.P. Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy. Life Sci. 59:1996;PL127-PL131.
15. Fagan S.C., Zarowitz B.J., Robert S. 'Brain attack': an indication for thrombolysis? Ann. Pharmacother. 26:1992;73-80.
16. C.M. Fisher, The history of cerebral embolism and hemorrhagic infarction, in: A.J. Furlan (Ed.), The Heart and Stroke, Springer-Verlag, 1987, pp. 1-16.
17. Germano I.M., Pitts L.H., Meldrum B.S., Bartkowski H.M., Simon R.P. Kynurenate inhibition of cell excitation decreases stroke size and deficit. Ann. Neurol. 22:1987;730-734.
18. Gill R., Lodge D. The neuroprotective efforts of the decahydroisoguinoline. LY 215490: a novel AMPA antagonist in focal ischaemia. Neuropharmacology. 33:1994;1529-1536.
19. Graham S.H., Chen J., LaN J., Leach M.J., Simon R.P. Neuroprotective efforts of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion. J. Pharmacol. Exp. Ther. 269:1994;854-859.
20. Graham S.H., Chen J., Sharp F.R., Simon R.P. Limiting ischemic injury by inhibition of excitatory amino acid release. J. Cereb. Blood Flow Metab. 13:1993;88-97.
21. Hamilton M.G., Lee J.S., Cummings P.J., Zabramski J.M. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits. Stroke. 25:1994;651-656.
22. Hirayama T., Ono H., Fukuda H. Effects of excitatory and inhibitory amino acid agonists and antagonists on ventral horn cells in slices of spinal cord isolated from adult rats. Neuropharmacology. 29:1990;1112-1117.
23. Hiroshi Yao., Ginsberg M.D., Watson B.D., Prado R., Dietrich W.D., Kraydieh S., Busto R. Failure of MK-801 to reduce infarct volume in thrombotic middle cerebral artery occlusion in rats. Stroke. 24:1993;864-871.
24. Johannessen S.I. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Epilepsia. 38:1997;S18-S23. Suppl. 1.
25. Johansen F.F., Diemer N.H. Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduce loss of hippocampal CA1 pyramidal cells. Acta Neurol. Scand. 84:1991;1-6.
26. Kanda T., Kurokawa M., Tamura S., Nakamura J., Ishii A., Kuwana Y., Serikawa T., Yamada J., Ishihara K., Sasa M. Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER). Life Sci. 59:1996;1607-1616.
27. Katsuta K., Nakanishi H., Shirakawa K., Yoshida K., Takagi K., Tamura A. The neuroprotective effort of the novel noncompetitive NMDA antagonist FR115427 in focal cerebral ischaemia in rats. J. Cereb. Blood Flow Metab. 15:1995;345-348.
28. Margaill I., Parmentier S., Callebert J., Allix M., Boulu R.G., Plotkine M. Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats. J. Cereb. Blood Flow Metab. 16:1996;107-113.
29. Meldrum B.S. Update on the mechanism of action of antiepileptic drugs. Epilepsia. 37:1996;S4-S11. Suppl. 6.
30. Overgaard K., Sereghy T., Boysen G., Pedersen H. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model. Scand. J. Clin. Lab. Invest. 53:1993;383-393.
31. Park C.K., McCulloch J., Kang J.K., Choi C.R. Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infraction and brain swelling in awake rats. Acta Neurochir. 127:1994;220-226.
32. Roberts E. γ-Aminobutyric acid and nervous system function: a perspective. Biochem. Pharmacol. 23:1974;2637-2649.
33. M.B. Rorick, R.J. Adams, Hemorrhagic infarction, in: H.H. Batjer (Ed.), Cerebrovascular Disease, Lippincott-Raven Publishers, Philadelphia, 1997, pp. 649-655.
34. Sanchez-Prieto J., Sihra T.S., Nicholls D.G. Characterization of the exocytotic release of glutamate from guinea pig cerebral cortical synaptosomes. J. Neurochem. 49:1987;58-64.
35. Sander J.W.A.S. Practical aspects of the use of topiramate in patients with epilepsy. Epilepsia. 38:1997;S56-S58. Suppl. 1.
36. Severt L., Coulter D.A., Sombati S., DeLorenzo R.J. Topiramate selectively blocks kainate currents in cultured hippocampal neurons. Epilepsia. 36:1995;38. Suppl. 4.
37. Shank R.P. Preclinical profile of topiramate, a novel anticonvulsant. Adv. AED Ther. 1:1995;1-6.
38. Shank R.P., Gardock J.F., Vanght J.L. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia. 35:1994;450-460.
39. Shuiab A., Mazagri A., Ijaz S. GABA agonist 'muscimol' is neuroprotective in repetitive transient forebrain ischaemia in gerbils. Exp. Neurol. 123:1993;284-288.
40. Shuiab A., Ijaz S., Kanthan R. Clomethiazole protects the brain in transient forebrain ischaemia when used up to 4 h after the insult. Neurosci. Lett. 197:1995;109-112.
41. Valtysson J., Hillered L., Andine P., Hagberg H., Persson L. Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation. Acta Neurochir. 129:1994;58-63.
42. Walker M.C., Sander J.W. Topiramate: a new antiepileptic drug for refractory epilepsy. Seizure. 5:1996;199-203.
43. Wauquier A., Zhou S. Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res. 24:1996;73-77.
44. White H.S. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia. 38:1997;S9-S17. Suppl. 1.
45. White H.S., Brown S.D., Skeen G.A., Wolf H.H., Twyman R.E. The anticonvulsant topiramate displays a unique ability to potentiate GABA-evoked currents. Epilepsia. 36:1995;39. Suppl. 3.
46. Yang Y., Shuaib A., Li Q., Miyashita H., Hewlett W. Effect of lamotrigine on extracellular level of glutamate and analine in reversible focal ischemia model of rat. Can. J. Neurol. Sci. 24:1997;S50. Suppl. 1.
47. Yang Y., Shuaib A., Li Q., Miyashita H., Hewlett W. Lamotirgine reduces the level of neuroactive substances in rat middle cerebral artery permanent occlusion model of focal ischaemia. Can. J. Neurol. Sci. 24:1997;S50. Suppl. 1.
48. Zhang Z., Zhang R.L., Jiang Q., Raman S.B.K., Cantwell L., Chopp M. A new rat model of thrombotic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 17:1997;123-135.